February 13, 2020
1 min watch

VIDEO: Neurotech implant shows positive safety profile

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

SAN FRANCISCO — At the Glaucoma 360: New Horizons Forum, Jeffrey L. Goldberg, MD, PhD, professor and chair of ophthalmology at Byers Eye Institute at Stanford University, discusses phase 2 data regarding an implant from Neurotech that releases ciliary neurotrophic factor.